P0 glycoprotein peptides 56-71 and 180-199 dose-dependently induce acute and chronic experimental autoimmune neuritis in Lewis rats associated with epitope spreading
Autor: | Peter H. van der Meide, Sigliti-Henrietta Pelidou, Michael Levi, Jie Zhu, Eilhard Mix, Bengt Winblad, Georgia Deretzi, Li-Ping Zou |
---|---|
Rok vydání: | 2001 |
Předmět: |
Male
medicine.medical_specialty Encephalomyelitis Autoimmune Experimental Encephalomyelitis Autoimmune Experimental/chemically induced/*immunology Immunology Neuritis Molecular Sequence Data Dose-Response Relationship Immunologic Inflammation In Vitro Techniques Guillain-Barre Syndrome Interferon-gamma Immune system Antigen Internal medicine Interferon-gamma/immunology/secretion Immunology and Allergy Medicine Animals Interferon gamma Amino Acid Sequence Myelin P0 Protein/chemistry/*immunology/*pharmacology chemistry.chemical_classification Immunodominant Epitopes/*immunology B-Lymphocytes Guillain-Barre syndrome business.industry Immunodominant Epitopes B-Lymphocytes/immunology Guillain-Barre Syndrome/immunology medicine.disease Peptide Fragments/immunology/pharmacology Peptide Fragments Rats Mononuclear cell infiltration Disease Models Animal Endocrinology Neurology chemistry Rats Inbred Lew Acute Disease Chronic Disease Neurology (clinical) medicine.symptom business Glycoprotein Myelin P0 Protein medicine.drug |
Zdroj: | Journal of neuroimmunology. 114(1-2) |
ISSN: | 0165-5728 |
Popis: | Two synthetic peripheral nerve myelin P0 protein peptides, an immunodominant (amino acids 180-199) and a cryptic (amino acids 56-71) one, induced an acute or chronic course of experimental autoimmune neuritis (EAN) in Lewis rats, when given at low dose (50-100 microg/rat) or high dose (250 microg/rat), respectively. Corresponding to the different clinical course, pathological changes and immune responses were found: (1) Onset of clinical signs of P0 peptide 56-71 (P0 56-71) induced EAN was 1-3 days later than in P0 peptide 180-199 (P0 180-199) induced EAN at all immunizing doses, whereas the peak of the disease occurred at a similar time point post immunization (p.i.), i.e. at days 14-16 p.i. in P0 56-71 induced EAN and at day 16 p.i. in P0 180-199 induced EAN. (2) Intramolecular epitope spreading as assessed by delayed type hypersensitivity response occurred in P0 56-71 induced EAN at both low and high antigen doses and in P0 180-199 induced EAN at high antigen dose (250 microg/rat) only. (3) P0 180-199 stimulated higher levels of interferon-gamma production in P0 180-199 induced EAN than in P0 56-71 induced EAN and vice versa. (4) Histopathologic evaluation revealed a similar grade of mononuclear cell infiltration in the sciatic nerves of both types of EAN, but more severe demyelination was found in P0 180-199 induced EAN compared to P0 56-71 induced EAN. The results support the hypothesis that high dose autoantigen immunization induces extensive determinant spreading and chronic course of autoimmune diseases. J Neuroimmunol |
Databáze: | OpenAIRE |
Externí odkaz: |